The direct involvement of CD147 with glycolysis was demonstrated through the CD147 knockdown in ALK+ ALCL cells, which led to the loss of MCT1 expression, reduction in glucose consumption, and retardation of tumor growth [96]. This evidence concerns the gene ALK and neoplasm.